Effect of dacarbacine (DTIC) on tumor growth in patients with metastatic neuroendocrine gastroenteropancreatic (GEP) tumors.

被引：1
|
作者：
Sprenger, A
Wied, M
Mueller, HH
Klose, K
Arnold, R
机构：
[1] Dept Internal Med, Marburg, Germany
[2] Dept Radiol, Marburg, Germany
[3] Univ Marburg, Marburg, Germany
来源：
GASTROENTEROLOGY | 2000年 / 118卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(00)84728-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
3290
引用
收藏
页码：A647 / A647
页数：1
相关论文
共 50 条
  • [1] Prognostic factors in patients with neuroendocrine gastroenteropancreatic (GEP) tumors.
    Sprenger, A
    Wied, M
    Mueller, HH
    Rickenbach, A
    Mathias, W
    Funk, R
    Arnold, R
    [J]. GASTROENTEROLOGY, 2000, 118 (04) : A514 - A514
  • [2] Growth behaviour and prognosis of patients with untreated metastatic or locally advanced gastroenteropancreatic (GEP) neuroendocrine tumors
    Badihian, T
    Sprenger, A
    Mueller, HH
    Klose, KJ
    Arnold, R
    [J]. GASTROENTEROLOGY, 2004, 126 (04) : A391 - A391
  • [3] Gastroenteropancreatic neuroendocrine tumors (GEP-NENs)
    Sebesta, Christian
    Feichter, Alexandra
    Selimi, Flonza
    [J]. WIENER MEDIZINISCHE WOCHENSCHRIFT, 2023, 173 (9-10) : 221 - 226
  • [4] Gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
    Kizilgul, Muhammed
    Delibasi, Tuncay
    [J]. TRANSLATIONAL GASTROINTESTINAL CANCER, 2015, 4 (01) : 39 - 56
  • [5] Tumor response in the CLARINET study of lanreotide depot vs. placebo in patients with metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
    Phan, Alexandria T.
    Dasari, Arvind
    Liyanage, Nilani
    Cox, David
    Lowenthal, Susan Pitman
    Wolin, Edward M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [6] Tumor Response in the CLARINET Study of Lanreotide Depot/Autogel vs Placebo in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
    不详
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (03) : 11 - 12
  • [7] Chromogranin A (CgA) serum levels correlate with hepatic tumor burden in patients with neuroendocrine gastroenteropancreatic (GEP) tumors
    Rinke, A
    Wilke, A
    Mayer, C
    Scherag, A
    Klose, KJ
    Arnold, R
    [J]. NEUROENDOCRINOLOGY, 2006, 83 (01) : 45 - 45
  • [8] Pathology classification of gastroenteropancreatic (GEP) neuroendocrine tumors (NET)
    Rindi, Guido
    [J]. ENDOCRINE JOURNAL, 2010, 57 : S279 - S279
  • [9] Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) Preface
    de Herder, Wouter W.
    [J]. BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2012, 26 (06) : 689 - 690
  • [10] Outcomes of locoregional treatment for unifocal progression in widespread metastatic gastroenteropancreatic neuroendocrine tumors.
    Al-Toubah, Taymeyah E.
    Cives, Mauro
    Anaya, Daniel A.
    Soares, Heloisa P.
    Strosberg, Jonathan R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
12345